122 related articles for article (PubMed ID: 9734566)
1. Sertindole versus haloperidol for schizophrenia.
Balon R
Am J Psychiatry; 1998 Sep; 155(9):1303-4. PubMed ID: 9734566
[No Abstract] [Full Text] [Related]
2. Sertindole versus haloperidol for schizophrenia.
Mattes JA
Am J Psychiatry; 1998 Sep; 155(9):1303; author reply 1303-4. PubMed ID: 9734567
[No Abstract] [Full Text] [Related]
3. Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. The Sertindole Study Group.
Daniel DG; Wozniak P; Mack RJ; McCarthy BG
Psychopharmacol Bull; 1998; 34(1):61-9. PubMed ID: 9564200
[TBL] [Abstract][Full Text] [Related]
4. Dose-response relationship of sertindole and haloperidol using the pharmacopsychometric triangle.
Bech P; Tanghøj P; Andreasson K; Overø KF
Acta Psychiatr Scand; 2011 Feb; 123(2):154-61. PubMed ID: 20560900
[TBL] [Abstract][Full Text] [Related]
5. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
Zimbroff DL; Kane JM; Tamminga CA; Daniel DG; Mack RJ; Wozniak PJ; Sebree TB; Wallin BA; Kashkin KB
Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505
[TBL] [Abstract][Full Text] [Related]
6. Sertindole in the long-term treatment of schizophrenia.
Hale AS; Azorin JM; Lemming OM; Mæhlum E
Int Clin Psychopharmacol; 2012 Jul; 27(4):231-7. PubMed ID: 22609816
[TBL] [Abstract][Full Text] [Related]
7. Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidol.
Gallhofer B; Jaanson P; Mittoux A; Tanghøj P; Lis S; Krieger S
Pharmacopsychiatry; 2007 Nov; 40(6):275-86. PubMed ID: 18030652
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine, sertindole and schizophrenia.
Drug Ther Bull; 1997 Nov; 35(11):81-3. PubMed ID: 9464002
[No Abstract] [Full Text] [Related]
9. A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophrenia.
Kane JM; Potkin SG; Daniel DG; Buckley PF
J Clin Psychiatry; 2011 Feb; 72(2):194-204. PubMed ID: 20673553
[TBL] [Abstract][Full Text] [Related]
10. Sertindole: a review of clinical efficacy.
Kane JM
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S59-63; discussion S63-4. PubMed ID: 9690972
[TBL] [Abstract][Full Text] [Related]
11. Sertindole : a review of its use in schizophrenia.
Murdoch D; Keating GM
CNS Drugs; 2006; 20(3):233-55. PubMed ID: 16529528
[TBL] [Abstract][Full Text] [Related]
12. Sertindole for the treatment of schizophrenia.
Azorin JM; Kaladjian A; Fakra E; Adida M
Expert Opin Pharmacother; 2010 Dec; 11(18):3053-64. PubMed ID: 21080854
[TBL] [Abstract][Full Text] [Related]
13. Drug safety and efficacy evaluation of sertindole for schizophrenia.
Karamatskos E; Lambert M; Mulert C; Naber D
Expert Opin Drug Saf; 2012 Nov; 11(6):1047-62. PubMed ID: 22992213
[TBL] [Abstract][Full Text] [Related]
14. A naturalistic pilot study comparing haloperidol, clozapine, sertindole, and risperidone in partially responsive chronic schizophrenia or schizoaffective disorder.
Fogelson DL; Sternbach H; Payne D
J Clin Psychopharmacol; 1997 Dec; 17(6):492-4. PubMed ID: 9408817
[No Abstract] [Full Text] [Related]
15. Efficacy and safety of sertindole in schizophrenia: a clinical review.
Zoccali RA; Bruno A; Muscatello MR
J Clin Psychopharmacol; 2015 Jun; 35(3):286-95. PubMed ID: 25830594
[TBL] [Abstract][Full Text] [Related]
16. Sertindole in the treatment of psychosis in schizophrenia: efficacy and safety.
Tamminga CA; Mack RJ; Granneman GR; Silber CJ; Kashkin KB
Int Clin Psychopharmacol; 1997 Feb; 12 Suppl 1():S29-35. PubMed ID: 9179641
[TBL] [Abstract][Full Text] [Related]
17. Sertindole in treating schizophrenia.
Hosp Med; 1998 Feb; 59(2):165. PubMed ID: 9797900
[No Abstract] [Full Text] [Related]
18. Sertindole, a new atypical antipsychotic for the treatment of schizophrenia.
Brown LA; Levin GM
Pharmacotherapy; 1998; 18(1):69-83. PubMed ID: 9469684
[TBL] [Abstract][Full Text] [Related]
19. Sertindole: new drug. Another "atypical" neuroleptic; QT prolongation.
Prescrire Int; 2007 Apr; 16(88):59-62. PubMed ID: 17458045
[TBL] [Abstract][Full Text] [Related]
20. FDG-PET and MRI imaging of the effects of sertindole and haloperidol in the prefrontal lobe in schizophrenia.
Buchsbaum MS; Haznedar M; Newmark RE; Chu KW; Dusi N; Entis JJ; Goldstein KE; Goodman CR; Gupta A; Hazlett E; Iannuzzi J; Torosjan Y; Zhang J; Wolkin A
Schizophr Res; 2009 Oct; 114(1-3):161-71. PubMed ID: 19695836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
